Product
Low-Dose Decitabine
1 clinical trial
4 indications
Indication
Diffuse Large B-Cell LymphomaIndication
Relapse/RecurrenceIndication
Extranodal ExtensionIndication
Primary central nervous system lymphomaClinical trial
Low-Dose Decitabine Plus Anti-PD-1 Treatment for Relapsed/Refractory Diffuse Large B Cell Lymphoma With Extranodal (Esp. Central Nervous System) Involvement: A PhaseⅡClinical TrialStatus: Recruiting, Estimated PCD: 2025-03-01